AK

Alok Kumar

Active Director Director DIN 10460742
DIN 10460742 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Alok Kumar

Data last updated:

Alok Kumar is a Director at Alphard Global Pharma Private Limited (since 2024). The company operates in Pharma. Alphard Global Pharma Private Limited reported revenue of ₹25 Lakh (FY 2025).

DIN 10460742
Primary Designation Director
Industry Pharma
First Appointment 17 Jan 2024
Oldest Company Age 2 yrs
Largest company Alphard Global Pharma Private Limited · ₹25 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jan 20242024₹25 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Alphard Global Pharma Private Limited
Premium access

Shareholding and investment profile for Alok Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alok Kumar

Alok Kumar currently holds 1 directorship: Alphard Global Pharma Private Limited (Director, since 17 Jan 2024, revenue ₹25 Lakh (FY 2025)).

Alok Kumar was first appointed on 17 Jan 2024 as Director at Alphard Global Pharma Private Limited.

The current boards of Alok Kumar's companies include Deepa Kumar (Alphard Global Pharma Private Limited), Divyanshu Singh (Alphard Global Pharma Private Limited), Revendra Kumar (Alphard Global Pharma Private Limited), Sudhansu Singh (Alphard Global Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available